Dual TLR7/8 Agonist (Birdie Biopharmaceuticals)

N/A

Report date: 2025/01/26 18:40:13
NME

Base Information

Drug NameDual TLR7/8 Agonist (Birdie Biopharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 7 agonistsToll like receptor 8 agonists
TargetsToll like receptor 7Toll like receptor 8
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBirdie Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesBirdie Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A